The effect of Citrus aurantium inhalation aromatherapy on chemotherapy-induced nausea and vomiting in breast cancer patients: a randomized controlled trial.

The short version

This randomized controlled trial with 92 breast cancer patients explored whether breathing in the scent of bitter orange (Citrus aurantium) essential oil could ease chemotherapy-induced nausea and vomiting (CINV) — sickness that standard anti-nausea drugs don't always fully control. CINV is typically split into an acute phase (the first 24 hours after treatment, driven mainly by serotonin release) and a delayed phase (roughly 1-5 days later, governed by different chemical signals including substance P). The study tested whether a simple, inhaled essential oil could specifically help with that harder-to-treat delayed phase. Ninety-two women undergoing AC-T chemotherapy for breast cancer (average age 48) were randomly assigned to inhale either bitter orange oil or a scentless sunflower-oil placebo — two drops on the upper lip, breathed in for 20 minutes, three times a day for five days, on top of their usual anti-nausea medication. Neither the patients, their nurses, nor the researcher analyzing the results knew who received which oil. Each day, patients rated their nausea, vomiting, and retching on the Rhodes Index, a validated 0-to-35 symptom scale. For the first two days, both groups fared about the same — expected, since standard medications already cover that early window well. But from Day 3 onward, the bitter-orange group pulled clearly ahead: by Day 5, their average total symptom score was roughly half the control group's (3.6 vs 7.1 out of 35, p=0.002), with similarly meaningful drops in vomiting (p=0.01), nausea (p=0.004), and retching (p=0.02) scores specifically. Within the aromatherapy group, symptoms dropped so much from Day 1 to Day 5 that the effect size was "very large" by conventional standards (Cohen's d=1.62 for total symptoms) — the placebo group barely moved at all over the same stretch. No one in either group reported side effects or discomfort from the oils. The pattern — no early benefit, a real one later — fits with what's known about the delayed phase of CINV being harder for drugs to reach and potentially more open to complementary approaches like aromatherapy. Because the trial didn't measure symptoms before treatment started and drew only from one clinic and one cancer type, these results need confirming in larger, more varied studies before bitter-orange aromatherapy becomes a routine recommendation — but as a cheap, safe add-on alongside standard antiemetics, the early signal here is encouraging.

Key findings

• In a controlled trial of 92 breast cancer patients, inhaling bitter orange (Citrus aurantium) essential oil three times a day for five days after chemotherapy meaningfully reduced nausea, vomiting, and retching compared to a scentless placebo oil.
• The benefit only showed up starting on Day 3 - the "delayed phase" of chemotherapy sickness (roughly 1 to 5 days after treatment) - not in the first two days, when standard anti-nausea medications already work well on their own.
• By Day 5, patients using the bitter orange oil had about half the total symptom score of the placebo group, and the improvement within the oil group was large enough (Cohen's d, a measure of how big an effect is = 1.62) to be considered a very strong result.
• No side effects, allergic reactions, or discomfort were reported from using either oil, suggesting bitter orange aromatherapy is a low-risk option to use alongside - never instead of - standard anti-nausea medication.
• Because the trial did not measure symptoms before treatment began and included only one clinic and one type of cancer, larger and more diverse studies are still needed before this becomes a routine recommendation.

Common questions